Exogenous administration of PGF2α upregulates the expression of C-X-C motif chemokine ligand 1 (CXCL-1), which is a chemoattractant for neutrophils and promotes neutrophil chemotaxis in endometrial adenocarcinoma [18]. This evidence concerns the gene CXCL1 and endometrium adenocarcinoma.